ResMed Inc.

NYSE:RMD

Medical - Devices

Healthcare
$242.61 +0.85%

+$1.58 today

Market cap
$34.12B
Beta
0.78
P/E (TTM)
18.1
EPS (TTM)
$10.37
Dividend yield
1.28%
52W Low $180.27High $293.81

Volume 1.22M

Average 1.32M

RMD Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

ResMed Inc.NYSE: RMD

Gross Margin · Q4 FY2026 · quarter ended Jun 2026

Gross margin narrows to 58.8%

Gross margin was 58.8% in Q4 FY2026, down 2.0 pp from a year earlier. On a trailing-twelve-month basis it was 61.2%, up 1.8 pp year over year. Over 3 fiscal years it widened by 5.3 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
58.8%-3.4 pp QoQ
Last fiscal yearJun 2026
61.1%+1.7 pp YoY
LTMJun 2026
61.2%+1.8 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-2.0 pp——
1 year+1.7 pp——
3 years+5.3 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2026
61.1%
Year-over-year change
+1.7pp

Gross Margin vs competitors

How RMD compares with its peers on the latest reported figures

  • RMD's LTM Jun 2026 gross margin of 61.2% is the 6th highest of the 9 companies compared; the peer median is 66.9%.
  • Its year-over-year change of +1.8 pp is the 4th highest of 9, against a peer median of +1.5 pp.
  • Over three fiscal years its change of +5.3 pp compares with a peer median of +1.5 pp.
RMD Competitors Peer median
Gross Margin for RMD and competitors
Company Period LTM level YoY 3-year change
INSPInspire Medical Systems, Inc.LTM Jun 202686.1% +1.7 pp+1.6 pp
ELMDElectromed, Inc.LTM Mar 202678.4% +0.9 pp+2.6 pp
BSXBoston Scientific CorporationLTM Jun 202671.2% +7.9 pp+8.2 pp
ISRGIntuitive Surgical, Inc.LTM Sep 202667.2% +0.8 pp-1.4 pp
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
RMDResMed Inc.LTM Jun 202661.2% +1.8 pp+5.3 pp
TFXTeleflex IncorporatedLTM Jun 202653.8% -1.8 pp+1.4 pp
PHGKoninklijke Philips N.V.LTM Jun 202645.9% +2.1 pp+4.8 pp
GEHCGE HealthCare Technologies Inc.LTM Jun 202642.9% +1.3 pp+0.8 pp
Peer median (excluding RMD) 66.9%+1.5 pp+1.5 pp

Competitors are the stored peer set for RMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue3.58B4.22B4.69B5.15B5.65B
Cost of Revenue1.55B1.87B2.03B2.09B2.2B
Gross Profit2.02B2.36B2.66B3.05B3.45B
Gross Margin56.6%55.8%56.7%59.4%61.1%
Research & Development253.58M287.64M307.53M331.28M378.29M
Selling, General & Admin739.37M874M917.14M991.02M1.12B
Operating Expenses1.02B1.22B1.34B1.37B1.54B
Depreciation & Amortization193.84M197.56M216.21M235.81M244.15M
EBITDA1.18B1.36B1.53B1.91B2.15B
EBITDA Margin32.9%32.2%32.7%37.2%38.1%
Operating Income1B1.13B1.32B1.69B1.91B
Operating Margin28.0%26.8%28.2%32.7%33.8%
Interest Income00000
Interest Expense22.31M47.38M45.71M12.61M0
Other Income / Expenses(39.8M)(30.21M)(55.1M)(7.8M)10.96M
Income Before Tax960.48M1.1B1.26B1.68B1.92B
Pre-Tax Margin26.8%26.1%27.0%32.6%34.0%
Income Tax Expense181.05M204.11M243.85M276.84M396.12M
Net Income779.44M897.56M1.02B1.4B1.52B
Net Margin21.8%21.3%21.8%27.2%26.9%
EPS (Basic)5.346.126.949.5510.44
EPS (Diluted)5.306.096.929.5110.40
Weighted Avg Shares146.07M146.77M147.02M146.72M144.71M
Weighted Avg Shares (Diluted)147.04M147.46M147.55M147.34M144.98M

ResMed Inc.

NYSE:RMD

Intrinsic Alpha fair value

Locked

Current Price

$242.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.